BRD2577 is a novel hydroxy-pyrimidine based HDAC inhibitor that acts by inhibiting multiple HDAC isoforms and modulating acetylation levels in cells. Histone deacetylases (HDACs) are enzymes involved in many important biological functions. They have been linked to a variety of cancers, psychiatric disorders, and other diseases. Since small molecules can serve as probes to study the relevant biological roles of HDACs, novel scaffolds are necessary to develop more efficient, selective drug candidates.

纯度：≥98%

CAS：353781-42-7